Back to search

Ireland· IE-PA-PA0690/020/001

Technescan MIBI 1mg kit for radiopharmaceutical preparation

A technetium (99mtc) sestamibi product containing tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate, registered in Ireland by Curium Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC V09GA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTechnescan MIBI 1mg kit for radiophar…ATCV09GA01REGISTER NO.IE-PA-PA0690/020/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Technetium (99mtc) sestamibi is registered in 11 of 19 countries.

Countries holding a registration under ATC V09GA01 (technetium (99mtc) sestamibi), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Technetium (99mtc) sestamibi · ATC V09GA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate
Manufacturer
Curium Netherlands B.V.
Country
Ireland (IE)
ATC code
V09GA01
ATC class
Technetium (99mTc) sestamibi
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0690/020/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abdd38b3-b812-40a0-a683-e34b28f6a74a
GET /v1/drugs/abdd38b3-b812-40a0-a683-e34b28f6a74a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit for radiopharmaceutical preparation",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "V09GA01"
  ],
  "strength": null,
  "pa_number": "PA0690/020/001",
  "substances": [
    "Tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "21/11/2008",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about technetium (99mtc) sestamibi.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.